Mark Ma - Publications, H-index & Citations

Do Firms Mimic Industry Leaders' Accounting? Evidence from Financial Statement Comparability

IF4.4

2024-10-03

PREAI

Billett, Matthew T.; Ma, Mark (Shuai); Yu, Xiaoyun

Economic consequences of operating lease recognition 经营租赁确认的经济后果

IF4.4

2023-09-27

PREAI

De Franco, Gus; Hou, Yu; Ma, Mark (Shuai)

Are Tax Havens and Offshore Financial Centers Cracked Down On? A Study on the International Standard of Exchange of Information on Request

IF6.8

2023-04-01

PREAI

Ma, Mark (Shuai); Thomas, Wayne B.

Transporting transparency: Director foreign experience and corporate information environment

IF4.4

2022-02-15

OAAI

Li, Yijun; Ma, Mark (Shuai)

JOURNAL OF INTERNATIONAL BUSINESS STUDIES

IF9

2022-01-26

PREAI

Liao, Guanmin; Ma, Mark (Shuai); Yu, Xiaoyun

The effect of tax avoidance crackdown on corporate innovation 避税打击对企业创新的影响

Agency costs and tax planning when the government is a major Shareholder 政府为大股东时的代理成本与税收筹划

IF6.8

2021-04-01

OAAI

Li, Qin; Ma, Mark (Shuai); Shevlin, Terry

GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service

IF6.8

2019-04-01

212

PREAI

Bradshaw, Mark; Liao, Guanmin; Ma, Mark (Shuai)

BMC GENOMICS

IF3.7

2018-01-19

OAAI

Wang, Yiqi; Li, Gen; Ma, Mark; He, Fazhong; Song, Zhuo; Zhang, Wei; Wu, Chengkun

Economic Links and the Spillover Effect of Earnings Quality on Market Risk 经济联系与盈余质量对市场风险的溢出效应

Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins

IF4.4

2017-02-01

PREAI

Ma, Mark (Shuai)

Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform

IF3.7

2016-01-19

OAAI

Kathman, Steven, Jr.; Thway, Theingi M.; Zhou, Lei; Lee, Stephanie; Yu, Steven; Ma, Mark; Chirmule, Naren; Jawa, Vibha

In Silico Evaluation of the Potential Impact of Bioanalytical Bias Difference between Two Therapeutic Protein Formulations for Pharmacokinetic Assessment in a Biocomparability Study

IF3.7

2015-08-12

OAAI

Talbot, Jeffrey J.; Calamba, Dominador; Pai, Melody; Ma, Mark; Thway, Theingi M.

Ligand Binding Assay Critical Reagents and Their Stability: Recommendations and Best Practices from the Global Bioanalysis Consortium Harmonization Team

IF3.7

2015-03-05

OAAI

Thway, Theingi M.; Macaraeg, Chris; Eschenberg, Michael; Ma, Mark

Tax avoidance and geographic earnings disclosure

IF3.7

2014-04-01

OAAI

King, Lindsay E.; Farley, Esme; Imazato, Mami; Keefe, Jeannine; Khan, Masood; Ma, Mark; Pihl, K. Susanne; Sriraman, Priya

Impact of Anti-Drug Antibodies in Preclinical Pharmacokinetic Assessment

IF6.8

2013-11-01

200

PREAI

Hope, Ole-Kristian; Ma, Mark (Shuai); Thomas, Wayne B.

Validation of a Ligand Binding Assay Using Dried Blood Spot Sampling

IF3.7

2013-05-08

OAAI

Thway, Theingi M.; Magana, Ivan; Bautista, Ami; Jawa, Vibha; Gu, Wen; Ma, Mark

Specific Method Validation and Sample Analysis Approaches for Biocomparability Studies of Denosumab Addressing Method and Manufacture Site Changes

IF3.7

2012-11-08

OAAI

Burns, Daniel; Brunner, Laura; Rajendran, Surendran; Johnson, Beth; Ma, Mark; Wang, Jin